Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Epistaxis01:30

Epistaxis

Epistaxis, or nosebleeds, occurs when small, swollen blood vessels in the nasal mucous membrane rupture. Typically, the anterior septum is the primary site of occurrence.
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
Chronic Pharyngitis01:23

Chronic Pharyngitis

Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Anatomy of Respiratory System I: Upper Respiratory Tract01:29

Anatomy of Respiratory System I: Upper Respiratory Tract

The upper respiratory tract plays a vital role in the respiratory system, comprising several structures that facilitate air intake and prepare air for the lungs. It also serves as the first line of defense against pathogens and particles. This tract includes the nose and nasal cavity, the oral cavity, the paranasal sinuses, and the pharynx, each with specific functions and features.
Nose and nasal cavity
The nose and nasal cavity represent the main external openings of the respiratory tract.
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Systemic Corticosteroids in the Management of Sinonasal Disease: An Evidence-Based Expert Review.

International forum of allergy & rhinology·2026
Same author

Sphenoid sinus pneumatization types, extensions and adjacent neurovascular structures: a systematic review with meta-analysis and meta-regression.

Anatomical science international·2026
Same author

Diving surgery for ACTH secreting pituitary adenomas: a retrospective single center cohort study.

British journal of neurosurgery·2026
Same author

Indirect Treatment Comparison of Tezepelumab Versus Other Biologics in Severe Chronic Rhinosinusitis with Nasal Polyps: A Systematic Literature Review and Network Meta-analysis.

Advances in therapy·2026
Same author

Choanal atresia repair in Europe and the world - a comprehensive investigation of the current state of care.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·2026
Same author

Multidisciplinary Consensus Statement for Appropriate Evaluation and Workup of Sinonasal Masses.

JAMA otolaryngology-- head & neck surgery·2026

Related Experiment Video

Updated: May 20, 2026

Immunofluorescent Labeling in Nasal Mucosa Tissue Sections of Allergic Rhinitis Rats via Multicolor Immunoassay
06:08

Immunofluorescent Labeling in Nasal Mucosa Tissue Sections of Allergic Rhinitis Rats via Multicolor Immunoassay

Published on: September 22, 2023

European Position Paper on Rhinosinusitis and Nasal Polyps 2012.

Wytske J Fokkens1, Valerie J Lund, Joachim Mullol

  • 1Department of Otorhinolaryngology, Academic Medical Center, Amsterdam, the Netherlands.

Rhinology. Supplement
|July 7, 2012
PubMed
Summary
This summary is machine-generated.

The 2012 European Position Paper updates guidelines for rhinosinusitis and nasal polyps, offering refined definitions and evidence-based management strategies for acute and chronic conditions in children and adults.

More Related Videos

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
03:40

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis

Published on: December 20, 2024

Related Experiment Videos

Last Updated: May 20, 2026

Immunofluorescent Labeling in Nasal Mucosa Tissue Sections of Allergic Rhinitis Rats via Multicolor Immunoassay
06:08

Immunofluorescent Labeling in Nasal Mucosa Tissue Sections of Allergic Rhinitis Rats via Multicolor Immunoassay

Published on: September 22, 2023

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
03:40

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis

Published on: December 20, 2024

Area of Science:

  • Otolaryngology
  • Allergy and Immunology
  • Respiratory Medicine

Background:

  • The European Position Paper on Rhinosinusitis and Nasal Polyps (EPOS) provides evidence-based guidelines.
  • Previous iterations were published in 2005 and 2007.
  • An updated comprehensive review is necessary to reflect current knowledge.

Purpose of the Study:

  • To provide an updated evidence-based guideline for the diagnosis and management of rhinosinusitis and nasal polyps.
  • To refine definitions and classifications, including difficult-to-treat cases and pediatric rhinosinusitis.
  • To present updated management strategies based on the latest scientific evidence.

Main Methods:

  • Systematic review and analysis of existing evidence on rhinosinusitis and nasal polyps.
  • Development of new definitions for disease control and difficult-to-treat rhinosinusitis.
  • Inclusion of extensive chapters on epidemiology, pathophysiology, and predisposing factors.

Main Results:

  • Introduced refined definitions for rhinosinusitis, including pediatric cases and difficult-to-treat conditions.
  • Differentiated between chronic rhinosinusitis with and without nasal polyps regarding pathophysiology and treatment.
  • Presented comprehensive analyses of epidemiological data, inflammatory mechanisms, and diagnostic approaches.

Conclusions:

  • The 2012 EPOS provides updated, evidence-based recommendations for rhinosinusitis and nasal polyps.
  • Emphasizes distinct approaches for acute versus chronic rhinosinusitis and differentiates management for CRS with and without nasal polyps.
  • Offers revised management schemes for both adult and pediatric populations, incorporating new insights into genetics, comorbidities, and upper/lower airway interactions.